Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the whole brain and spine. This treatment may also be referred to as whole central nervous system (CNS) or cranio-spinal radiotherapy.
-
Information covering a range of conditions. Search by condition name or condition type (specialty).
File results
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
FOI201779 Arthritis treatments for patients
-
FOI201776 Serious incidents and deaths of patients with a learning disability
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema
-
FOI/2023/0505 - Telecommunications infrastructure contract
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0508 - Lynch syndrome clinical pathway
-
FOI/2023/0509 - Immunoglobulin treatments
-
FOI/2023/0523 - Treatment on Nivolumab